SCHEMBL8686283

SCHEMBL8686283

Fc1ccc(N(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2D6 P10635 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ CRHBP P24387 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ CRHR2 Q13324 1/20 0.46
▸ TLR9 Q9NR96 1/20 0.46
▸ TSHR P16473 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ NFE2L2 Q16236 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13721098 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL16707557 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL13721514 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL13720765 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL13721274 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL13720906 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL23988628 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL20408053 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL13721346 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2
SCHEMBL13720842 1.00 ALDH1A1 (0.56) ALDH1A1L3MBTL1TDP1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986137-A Triarylamine fracturing tracer, tracing method, fracturing fluid and application 中国石油化工股份有限公司 2024-05-07 — — CN claimed
CN-118890906-A Application of solid additive in organic solar cell and cell preparation method 国科大杭州高等研究院 2024-11-01 — — CN disclosed
CN-117986137-A Triarylamine fracturing tracer, tracing method, fracturing fluid and application 中国石油化工股份有限公司 2024-05-07 — — CN disclosed
CN-112768622-B Quantum dot layer preparation method, QLED device preparation method and QLED device 广东聚华印刷显示技术有限公司 2023-03-24 — — CN disclosed
CN-112768622-A Quantum dot layer preparation method, QLED device preparation method and QLED device 广东聚华印刷显示技术有限公司 2021-05-07 — — CN disclosed
US-20200358022-A1 METHOD FOR PRODUCING ORGANIC THIN FILM, ORGANIC THIN FILM, AND USE THEREOF HITACHI CHEMICAL CO LTD (JP) 2020-11-12 — — US disclosed
WO-2020207309-A1 POLYTRIARYLAMINE AND USE THEREOF NEUDRIVE LIMITED (GB) 2020-10-15 — — WO disclosed
EP-3309804-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION AND OXIDE SEMICONDUCTOR ELECTRODE Fujifilm Corporation (JP) 2018-04-18 — — EP disclosed
EP-2799422-B1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER UNIV NAGOYA NAT UNIV CORP (JP) 2018-02-14 — — EP disclosed
EP-2615657-B1 ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC THIN FILM, FIELD-EFFECT TRANSISTOR, AND MANUFACTURING METHOD THEREFOR NIPPON KAYAKU KK (JP) 2016-12-21 — — EP disclosed
US-20140378692-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-12-25 — — US disclosed
EP-2799422-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER National University Corporation Nagoya University (JP) 2014-11-05 — — EP disclosed
US-20140141364-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, METHOD FOR PRODUCING ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS CANON KABUSHIKI KAISHA (JP) 2014-05-22 — — US disclosed
US-20140141363-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, METHOD FOR PRODUCING ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS CANON KABUSHIKI KAISHA (JP) 2014-05-22 — — US disclosed
EP-2615657-A1 ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC THIN FILM, FIELD-EFFECT TRANSISTOR, AND MANUFACTURING METHOD THEREFOR Nippon Kayaku Kabushiki Kaisha (JP) 2013-07-17 — — EP disclosed
US-20120313086-A1 Organic Semiconductor Material, Organic Semiconductor Composition, Organic Thin Film, Field-Effect Transistor, And Manufacturing Method Therefor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-12-13 — — US disclosed
CN-101963767-B Method for preparing single-layer electropositive organic photoconductor drum HANDAN PHOTOC TECHNOLOGIES CO LTD 2011-12-28 — — CN disclosed
CN-101963767-A Method for preparing single-layer electropositive organic photoconductor drum HANDAN PHOTOC TECHNOLOGIES CO LTD 2011-02-02 — — CN disclosed
CN-1199414-A Polymers contg. triarylamine units for use as electroluminescent materials HOECHST RES & TECH GMBH & CO (DE) 1998-11-18 — — CN disclosed
US-5814244-A POLYARYLENEVINYLENES, LOW THRESHOLD VOLTAGE AND HIGH EFFICIENCY HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378692-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER ADH5, ADH1C, ADH1A ALDH1A1 485/4885L3MBTL1 4152/4885TDP1 4241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback